Indra Mani

Dr. Indra Mani

Department of Microbiology, Gargi College, University of Delhi (DU), New Delhi, India.
orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 August 2022 in Bioengineering & Translational Medicine
Verified
Journal Article
Open access
KKKhushal Khambhati
Khushal Khambhati
GBGargi Bhattacharjee
Gargi Bhattacharjee
NGNisarg Gohil
Nisarg Gohil
GDGurneet K. Dhanoa
Gurneet K. Dhanoa
ASAntonia P. Sagona
Antonia P. Sagona
Vijai SinghVijai Singh
Vijai Singh
Antibiotic resistance ranks among the top threats to humanity. Due to the frequent use of antibiotics, society is facing a high prevalence of multidrug resistant pathogens, which have managed to evolve mechanisms that help them evade the last line of therapeutics. An alternative to antibiotics could involve the use of bacteriophages (phages), which are the natural predators of bacterial cells. In earlier times, phages were implemented as therapeutic agents for a century but were mainly replaced with antibiotics, and considering the menace of antimicrobial resistance, it might again become of interest due to the increasing threat of antibiotic resistance among pathogens. The current understanding of phage biology and clustered regularly interspaced short palindromic repeats (CRISPR) assisted phage genome engineering techniques have facilitated to generate phage variants with unique therapeutic values. In this review, we briefly explain strategies to engineer bacteriophages. Next, we highlight the literature supporting CRISPR‐Cas9‐assisted phage engineering for effective and more specific targeting of bacterial pathogens. Lastly, we discuss techniques that either help to increase the fitness, specificity, or lytic ability of bacteriophages to control an infection.

8 February 2022 in Journal of Controlled Release
Verified
Journal Article
Closed access
GBGargi Bhattacharjee
Gargi Bhattacharjee
NGNisarg Gohil
Nisarg Gohil
KKKhushal Khambhati
Khushal Khambhati
Indra ManiIndra Mani
Indra Mani
RMRupesh Maurya
Rupesh Maurya
Vijai SinghVijai Singh
Vijai Singh

1 July 2016 in Renewable and Sustainable Energy Reviews
Verified
Journal Article
Closed access
VSVijai Singh
Vijai Singh
DCDharmendra Kumar Chaudhary
Dharmendra Kumar Chaudhary
Indra ManiIndra Mani
Indra Mani
PDPawan Kumar Dhar
Pawan Kumar Dhar

1 June 2014 in Molecular Pharmacology
Verified
Journal Article
Closed access
PDF file
PKPrerna Kumar
Prerna Kumar
RPRamu Periyasamy
Ramu Periyasamy
SDSubhankar Das
Subhankar Das
SNSmitha Neerukonda
Smitha Neerukonda
Indra ManiIndra Mani
Indra Mani
Kailash PandeyKailash Pandey
Kailash Pandey
The objective of the present study was to delineate the mechanisms of GC-A/natriuretic peptide receptor-A (GC-A/NPRA) gene (Npr1) expression in vivo. We used all-trans retinoic acid (ATRA) and histone deacetylase (HDAC) inhibitor, sodium butyrate (NaBu) to examine the expression and function of Npr1 using gene-disrupted heterozygous (1-copy; +/−), wild-type (2-copy; +/+), and gene-duplicated heterozygous (3-copy; ++/+) mice. Npr1+/− mice exhibited increased renal HDAC and reduced histone acetyltransferase (HAT) activity; on the contrary, Npr1++/+ mice showed decreased HDAC and enhanced HAT activity compared with Npr1+/+ mice. ATRA and NaBu promoted global acetylation of histones H3-K9/14 and H4-K12, reduced methylation of H3-K9 and H3-K27, and enriched accumulation of active chromatin marks at the Npr1 promoter. A combination of ATRA-NaBu promoted recruitment of activator-complex containing E26 transformation–specific 1, retinoic acid receptor α, and HATs (p300 and p300/cAMP response element–binding protein-binding protein–associated factor) at the Npr1 promoter, and significantly increased renal NPRA expression, GC activity, and cGMP levels. Untreated 1-copy mice showed significantly increased systolic blood pressure and renal expression of α-smooth muscle actin (α-SMA) and proliferating cell nuclear antigen (PCNA) compared with 2- and 3-copy mice. Treatment with ATRA and NaBu synergistically attenuated the expression of α-SMA and PCNA and reduced systolic blood pressure in Npr1+/− mice. Our findings demonstrate that epigenetic upregulation of Npr1 gene transcription by ATRA and NaBu leads to attenuation of renal fibrotic markers and systolic blood pressure in mice with reduced Npr1 gene copy number, which will have important implications in prevention and treatment of hypertension-related renal pathophysiological conditions.

1 July 2016 in Physiological Genomics
Verified
Journal Article
Closed access
PDF file
USUmadevi Subramanian
Umadevi Subramanian
PKPrerna Kumar
Prerna Kumar
Indra ManiIndra Mani
Indra Mani
DCDavid Chen
David Chen
IKIsaac Kessler
Isaac Kessler
Kailash PandeyKailash Pandey
Kailash Pandey
The objective of the present study was to examine the genetically determined differences in the natriuretic peptide receptor-A (NPRA) gene ( Npr1) copies affecting the expression of cardiac hypertrophic markers, proinflammatory mediators, and matrix metalloproteinases (MMPs) in a gene-dose-dependent manner. We determined whether stimulation of Npr1 by all-trans retinoic acid (RA) and histone deacetylase (HDAC) inhibitor sodium butyric acid (SB) suppress the expression of cardiac disease markers. In the present study, we utilized Npr1 gene-disrupted heterozygous ( Npr1+/−, 1-copy), wild-type ( Npr1+/+, 2-copy), gene-duplicated ( Npr1++/+, 3-copy) mice, which were treated intraperitoneally with RA, SB, and a combination of RA/SB, a hybrid drug (HB) for 2 wk. Untreated 1-copy mice showed significantly increased heart weight-body weight (HW/BW) ratio, blood pressure, hypertrophic markers, including beta-myosin heavy chain (β-MHC) and proto-oncogenes (c-fos and c-jun), proinflammatory mediator nuclear factor kappa B (NF-κB), and MMPs (MMP-2, MMP-9) compared with 2-copy and 3-copy mice. The heterozygous (haplotype) 1-copy mice treated with RA, SB, or HB, exhibited significant reduction in the expression of β-MHC, c-fos, c-jun, NF-κB, MMP-2, and MMP-9. In drug-treated animals, the activity and expression levels of HDAC were significantly reduced and histone acetyltransferase activity and expression levels were increased. The drug treatments significantly increased the fractional shortening and reduced the systolic and diastolic parameters of the Npr1+/− mice hearts. Together, the present results demonstrate that a decreased Npr1 copy number enhanced the expression of hypertrophic markers, proinflammatory mediators, and MMPs, whereas an increased Npr1 repressed the cardiac disease markers in a gene-dose-dependent manner.

21 July 2022
Verified
Book Chapter
Closed access
AGAeshna Gupta
Aeshna Gupta
VSVijai Singh
Vijai Singh
Indra ManiIndra Mani
Indra Mani